Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

Objectives: To establish the frequency of cognitive impairment in a population based sample of patients with recently diagnosed relapsing-remitting multiple sclerosis (RRMS), and to determine the relation between cognitive abnormalities and the extent of macroscopic and microscopic tissue damage revealed by magnetic resonance imaging (MRI) and magnetisation transfer (MT) imaging. Methods: 58 patients with RRMS consecutively diagnosed in the previous six months in Aquitaine and 70 healthy controls underwent a battery of neuropsychological tests. Lesion load and atrophy indices (brain parenchymal fraction and ventricular fraction) were measured on brain MRI. MT ratio (MTR) histograms were obtained from lesions, normal appearing white matter (NAWM), and normal appearing grey matter (NAGM). Gadolinium enhanced lesions were counted. Results: 44 RRMS patients could be individually matched with healthy controls for age, sex, and education. Patients performed worse in tests of verbal and spatial memory, attention, information processing speed, inhibition, and conceptualisation. Measures of attention and information processing speed were correlated with lesion load, mean NAWM MTR, and the peak location of the NAGM MTR histogram in the patients. Multivariate regression analysis showed that lesion load and mean NAWM MTR were among the MR indices that were most significantly associated with impairment of attention and information processing speed in these early RRMS cases. Conclusions: Cognitive impairment appears to be common in the early stages of RRMS, mainly affecting attention, information processing speed, memory, inhibition, and conceptualisation. The severity of these deficits reflects the extent of the lesions and the severity of tissue disorganisation outside lesions.

[1]  V. Dousset,et al.  Biology: The Significance of MR Parameters in Multiple Sclerosis , 2004 .

[2]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis: a review of recent developments. , 2003, Current opinion in neurology.

[3]  A Achiron,et al.  Cognitive impairment in probable multiple sclerosis , 2003, Journal of neurology, neurosurgery, and psychiatry.

[4]  Paul S. Tofts,et al.  Quantitative MRI of the brain : measuring changes caused by disease , 2003 .

[5]  A. Richards,et al.  Stroop interference and negative priming in patients with multiple sclerosis , 2002, Neuropsychologia.

[6]  F. Barkhof,et al.  Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue , 2002, Multiple sclerosis.

[7]  H. Amièva,et al.  Inhibitory Breakdown and Dementia of the Alzheimer Type: A General Phenomenon? , 2002, Journal of clinical and experimental neuropsychology.

[8]  L. Mancuso,et al.  Comparison of two brief neuropsychological batteries in people with multiple sclerosis , 2002, Multiple sclerosis.

[9]  M. Rovaris,et al.  Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging , 2002, Journal of the Neurological Sciences.

[10]  A J Thompson,et al.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[11]  Rohit Bakshi,et al.  Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. , 2002, Archives of neurology.

[12]  R. Bakshi,et al.  Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[13]  C H Polman,et al.  The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice , 2001, Multiple sclerosis.

[14]  G Cazzato,et al.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[15]  R. Zivadinov,et al.  MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis , 2001, Neuroradiology.

[16]  F. Barkhof,et al.  Concurrent validity of the MS Functional Composite using MRI as a biological disease marker , 2001, Neurology.

[17]  R. Kikinis,et al.  Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. , 2001, Archives of neurology.

[18]  Gianpaolo Donzelli,et al.  Catch-Up Growth in Short-at-Birth NICU Graduates , 2000, Hormone Research in Paediatrics.

[19]  A. Thompson,et al.  Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR , 2000, Multiple sclerosis.

[20]  Moses Rodriguez,et al.  Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. , 2000, Brain : a journal of neurology.

[21]  J K Udupa,et al.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. , 2000, Radiology.

[22]  M Rovaris,et al.  Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[23]  M Rovaris,et al.  Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[24]  Marco Rovaris,et al.  Assessment of the damage of the cerebral hemispheres in MS using neuroimaging techniques , 2000, Journal of the Neurological Sciences.

[25]  G Cutter,et al.  Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. , 2000, Multiple sclerosis.

[26]  R I Grossman,et al.  MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis. , 1999, AJNR. American journal of neuroradiology.

[27]  R. Rudick,et al.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS , 1999, Neurology.

[28]  B. Sharrack,et al.  The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis , 1999, Multiple sclerosis.

[29]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[30]  R. Herndon,et al.  A longitudinal study of brain atrophy in relapsing multiple sclerosis , 1999, Neurology.

[31]  A. Thompson,et al.  Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. , 1999, Brain : a journal of neurology.

[32]  Stephen M. Rao,et al.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.

[33]  L D Blumhardt,et al.  Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis , 1999, Journal of neurology, neurosurgery, and psychiatry.

[34]  A. Revonsuo,et al.  Semantic memory deficit in multiple sclerosis; impaired understanding of conceptual meanings , 1999, Journal of the Neurological Sciences.

[35]  V. Dousset,et al.  Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. , 1999, Neurology.

[36]  Massimo Filippi,et al.  Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis , 1998, Journal of the Neurological Sciences.

[37]  M Rovaris,et al.  Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis , 1998, Neurology.

[38]  ichard,et al.  AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS , 1998 .

[39]  L. Pelosi,et al.  Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. , 1997, Brain : a journal of neurology.

[40]  J. Ruutiainen,et al.  The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. , 1997, Brain : a journal of neurology.

[41]  J Foong,et al.  Executive function in multiple sclerosis. The role of frontal lobe pathology. , 1997, Brain : a journal of neurology.

[42]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[43]  L. Grattan,et al.  The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study , 1995, Multiple sclerosis.

[44]  L. Amaducci,et al.  Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. , 1995, Archives of neurology.

[45]  J. Grafman,et al.  Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis , 1994, Neurology.

[46]  M. Ron,et al.  Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[47]  Y. Higashida,et al.  Detection of subtle microcalcifications: comparison of computed radiography and screen-film mammography. , 1992, Radiology.

[48]  R I Grossman,et al.  Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.

[49]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[50]  E. Warrington,et al.  Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study , 1991, Psychological Medicine.

[51]  M M Mesulam,et al.  Large‐scale neurocognitive networks and distributed processing for attention, language, and memory , 1990, Annals of neurology.

[52]  V. Haughton,et al.  Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis , 1989, Neurology.

[53]  T. Petersen,et al.  Erectile dysfunction in multiple sclerosis , 1988, Neurology.

[54]  P. A. Beatty,et al.  Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis. , 1988, Archives of neurology.

[55]  A. V. Zomeren,et al.  Cognitive impairment in patients with multiple sclerosis and mild physical disability. , 1987, Archives of neurology.

[56]  R. Jouvent,et al.  Cognitive function in recent-onset demyelinating diseases. , 1986, Archives of neurology.

[57]  R. Snaith,et al.  Grade Scores of the Montgomery—Åsberg Depression and the Clinical Anxiety Scales , 1986, British Journal of Psychiatry.

[58]  T. Hammeke,et al.  Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment. , 1985, Archives of neurology.

[59]  R. Heaton,et al.  Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. , 1985, Journal of consulting and clinical psychology.

[60]  I Grant,et al.  Deficient learning and memory in early and middle phases of multiple sclerosis. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[61]  E. Kaplan,et al.  The Boston naming test , 2001 .

[62]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[63]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[64]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[65]  D. Wechsler Manual for the Wechsler Adult Intelligence Scale. , 1955 .